JMP Securities Reaffirms Market Outperform Rating for Blueprint ...
19 hours ago · Blueprint Medicines (NASDAQ:BPMC - Get Free Report) 's stock had its "market outperform" rating reissued by analysts at JMP Securities in a research report issued on …
OFF
JMP Securities Reaffirms Their Buy Rating On BlackLine (BL)
2 weeks from now
1 day ago · JMP Securities analyst Patrick Walravens maintained a Buy rating on BlackLine (BL – Research Report) today and set a price target of $86.00. The company’s shares closed …
businessinsider.com
OFF
JMP Securities Reiterates "Market Outperform" Rating For …
2 weeks from now
Dec 18, 2024 · Northland Securities restated an "outperform" rating and issued a $440.00 price target (up previously from $400.00) on shares of Salesforce in a report on Wednesday, …
marketbeat.com
OFF
JMP Securities Reaffirms "Market Perform" Rating For Incyte …
2 weeks from now
1 day ago · Finally, Bank of America upgraded shares of Incyte from a "neutral" rating to a "buy" rating and increased their target price for the company from $68.00 to $90.00 in a research …
marketbeat.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
